Home > Products > B Cell Lymphoma A20-HL Idiotype & CD3 > Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Tandem scFv-Fc)

Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Tandem scFv-Fc)  (CAT#: BSFVF-015)

Recombinant Anti-B cell lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-B cell lymphoma A20-HL Idiotype/CD3 tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.
Datasheet INQUIRY

Specifications

Targets
B Cell Lymphoma A20-HL Idiotype & CD3
Type
Constant Domain-extended Bispecific Fragments
Species Reactivity
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma

Targets

Target 1
B Cell Lymphoma A20-HL Idiotype
Alternative Names
B cell lymphoma A20-HL Idiotype; B cell lymphoma; A20-HL; Idiotype; Id
Target 2
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3; AI504783
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B Cell Lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-015). Click the button below to contact us or submit your feedback about this product.